FDA reviewing reports of liver injury with orlistat
Links shared publicly online about this topic.
- 1,797total visits
FDA reviewing reports of liver injury with orlistat
View full resource at endocrinetoday.com
Tags: Liver, Obesity Medication, FDA, Xenical
Most Recently Shared on August 25, 2009 at 9:02 pm By:
#FDA reviewing reports of liver injury with #orlistat. Read about the early communication review here @ http://ow.ly/ljAu
FDA: Rare Cases Of Liver Injury Reported With Use Of Xenical, Alli
medicalnewstoday.com — “The U.S. Food and Drug Administration advised consumers and health care professionals about potential rare occurrences of severe liver injury in patients taking the weight-loss medication orlistat” View full resource at medicalnewstoday.com
Most Recently Shared on May 27, 2010 at 5:20 pm By:
FDA: Rare Cases Of Liver Injury Reported With Use Of Xenical, Alli http://mnt.to/3DbC #liver #hepatitis
Xenical and Alli labeling updated to include reports of severe liver injury - MPR
empr.com — “The FDA has notified healthcare professionals and patients that it has approved revised labeling for Xenical (orlistat, from Roche) and Alli (orlistat, from GlaxoSmithKline) to include new safety information about cases of severe liver injury that have been reported rarely with the use of this medication.” View full resource at empr.com
Most Recently Shared on May 26, 2010 at 6:39 pm By:
MPR News: Xenical and Alli labeling updated to include reports of severe liver injury: The FDA has notified health... http://bit.ly/cOCLAF
FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury
fda.gov — “FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury” View full resource at fda.gov
Most Recently Shared on May 26, 2010 at 3:22 pm By:
FDA: Rare Cases of Liver Injury Reported with Use of Xenical, Alli. http://lb.vg/rx61z
FDA Issues Early Communication About Ongoing Safety Review Of Weight Loss Drug Orlistat
medicalnewstoday.com — “The U.S. Food and Drug Administration announced that it is reviewing adverse event reports of liver injury in patients taking the weight loss drug orlistat, marketed as the prescription drug Xenic” View full resource at medicalnewstoday.com
Most Recently Shared on January 24, 2010 at 2:30 am By:
FDA Issues Early Communication About Ongoing Safety Review Of Weight Loss Drug Orlistat: The U.S. Food and Drug .. http://bit.ly/i2t2n
FDA Alert: Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety Review
drugs.com — “FDA Alert: Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety Review” View full resource at drugs.com
Most Recently Shared on August 25, 2009 at 10:08 pm By:
FDA Alert - FDA Reviewing Reports of Liver Failure with Weight Loss Drug Orlistat (marketed as Alli and Xenical) - http://bit.ly/3E8nyv
Medical News: Reports of Liver Injury Prompt FDA Review of Diet Drug - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA said it has received 32 reports of serious liver injury -- including six cases of liver failure -- among users of diet drug orlistat, which is sold as a prescription drug under t” View full resource at medpagetoday.com
Most Recently Shared on August 25, 2009 at 5:50 pm By:
Diet drug Orlistat (aka Xenical or Alli) is suspected in 32 liver damage cases, most occurring outside the U.S. http://bit.ly/FsLhG
FDA warns of hepatotoxicity risk with Xenical and Alli (orlistat) - MPR
empr.com — “The FDA has notified healthcare professionals and consumers that it is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat, which is marketed in the U.S. as Xenical (from Roche) and Alli (from GlaxoSmithKline).” View full resource at empr.com
Most Recently Shared on August 25, 2009 at 3:12 pm By:
MPR News: FDA warns of hepatotoxicity risk with Xenical and Alli (orlistat): The FDA has notified healt.. http://bit.ly/BdTnB
Advertisement

